Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunological response after SARS-CoV-2 infection and mRNA vaccines in patients with myasthenia gravis treated with Rituximab. | Neuromuscul Disord | 2023 | 36842303 | PubTator, text mining | PubMed |
| Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review. | Int J Mol Sci | 2023 | 36835142 | PubTator, text mining | PubMed |
| Comparison of Short-Term Post-Thymectomy Outcomes by Time-Weighted Dosages of Drug Requirements between Thymoma and Non-Thymoma Myasthenia Gravis Patients. | Int J Environ Res Public Health | 2023 | 36833734 | PubTator, text mining | PubMed |
| Binary Bamboo Forest Growth Optimization Algorithm for Feature Selection Problem. | Entropy (Basel) | 2023 | 36832680 | PubTator, text mining | PubMed |
| Frequency and Correlates of Mild Cognitive Impairment in Myasthenia Gravis. | Brain Sci | 2023 | 36831713 | PubTator, text mining | PubMed |
| Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis. | Biomedicines | 2023 | 36830985 | PubTator, text mining | PubMed |
| Therapeutic Plasma Exchange in Certain Immune-Mediated Neurological Disorders: Focus on a Novel Nanomembrane-Based Technology. | Biomedicines | 2023 | 36830870 | PubTator, text mining | PubMed |
| Proteome-Wide Detection and Annotation of Receptor Tyrosine Kinases (RTKs): RTK-PRED and the TyReK Database. | Biomolecules | 2023 | 36830638 | PubTator, text mining | PubMed |
| Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An Update. | Bioengineering (Basel) | 2023 | 36829670 | PubTator, text mining | PubMed |
| Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis. | Nat Biotechnol | 2023 | 36823355 | PubTator, text mining | PubMed |
| Sarcopenia: Molecular regulatory network for loss of muscle mass and function. | Front Nutr | 2023 | 36819699 | PubTator, text mining | PubMed |
| Exon definitive regions for MPC1 microexon splicing and its usage for splicing modulation. | Mol Ther Nucleic Acids | 2023 | 36817727 | PubTator, text mining | PubMed |
| Cellular interplay in skeletal muscle regeneration and wasting: insights from animal models. | J Cachexia Sarcopenia Muscle | 2023 | 36811134 | PubTator, text mining | PubMed |
| Comparison between mono-tacrolimus and mono-glucocorticoid in the treatment of myasthenia gravis. | Ann Clin Transl Neurol | 2023 | 36808840 | PubTator, text mining | PubMed |
| COVID-19 vaccination in myasthenia gravis: safe, but predictors of disease exacerbation yet to be determined. | Neurol Sci | 2023 | 36808584 | PubTator, text mining | PubMed |
| The diagnostic and prognostic utility of repetitive nerve stimulation in patients with myasthenia gravis. | Sci Rep | 2023 | 36806815 | PubTator, text mining | PubMed |
| C9orf72 poly-GA proteins impair neuromuscular transmission. | Zool Res | 2023 | 36799225 | PubTator, text mining | PubMed |
| Two patients with congenital myasthenic syndrome caused by COLQ gene mutations and the consequent ColQ protein defect. | Heliyon | 2023 | 36798769 | PubTator, text mining | PubMed |
| Inflammation and autoimmune myasthenia gravis. | Front Immunol | 2023 | 36793733 | PubTator, text mining | PubMed |
| Treatment considerations in myasthenia gravis for the pregnant patient. | Expert Rev Neurother | 2023 | 36786092 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=30